文献速递产科

产后女性阿片类药物处方模式

Opioid prescribing patterns among postpartum women.
PubMed 文献 · Am J Obstet Gynecol · 2018-04-07

该回顾性队列研究纳入单中心一年内12326例分娩女性,阴道分娩后30.4%、剖宫产术后86.7%在出院时获阿片类处方。出院阿片类吗啡毫克当量中位数阴道分娩200、剖宫产300,处方量未随出院前主观或客观疼痛评估而变化。

要点

  • 阴道分娩后30.4%、剖宫产术后86.7%出院时获阿片类处方。
  • 出院吗啡毫克当量中位数阴道分娩200、剖宫产300。
  • 出院前疼痛评分或住院末24小时阿片用量不影响处方量。

核心结论

  • 产后女性出院时普遍获阿片类处方,吗啡毫克当量范围宽,缺乏标准化。
  • 无论阴道分娩或剖宫产,处方量不随出院前主观或客观疼痛评估而不同。

研究设计与样本

  • 单中心高危重症监护中心一年内所有分娩的回顾性队列研究。
  • 排除近期阿片使用或产程、分娩、产后出现预期增加疼痛的罕见非 routine 事件者。
  • 共12611例女性中12326例符合纳入,阴道分娩9038例、剖宫产3288例。

主要发现

  • 阴道分娩后30.4%、剖宫产术后86.7%获出院阿片类处方。
  • 获处方者出院吗啡毫克当量中位数阴道分娩200(四分位距120-300)、剖宫产300(四分位距200-300)。
  • 获处方者中阴道分娩45.7%、剖宫产18.5%在住院最后一日使用0吗啡毫克当量。
  • 阴道分娩26.5%、剖宫产18.5%在出院前报告疼痛评分0分(满分10分)。
  • 无论分娩方式,出院前疼痛评分0分与>0分者处方量无差异;剖宫产者住院末24小时用0与>0吗啡毫克当量者处方量亦无差异。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Women commonly receive opioid prescriptions following hospitalization. The rise of the opioid epidemic in the United States underscores the importance of a better understanding of prescribing patterns. Although delivery is the most frequent reason for hospitalization in the United States, there is inadequate knowledge regarding opioid prescribing at postpartum hospital discharge. OBJECTIVE: We sought to describe opioid prescribing patterns at the time of discharge following delivery in a large, diverse cohort, and to describe the relationship of these patterns with objective and subjective measures of pain prior to discharge. STUDY DESIGN: This is a retrospective cohort study of all deliveries at a single, high-volume tertiary care center over a 1-year period. Women were excluded from analysis if they had evidence of recent opioid use, or their labor, delivery, or postpartum course was notable for rare, nonroutine events anticipated to increase pain. Medical records were queried for demographic and clinical data, including whether an opioid prescription was provided at discharge, and if so, details of that prescription. The primary outcome was amount of opioid morphine milligram equivalents prescribed at discharge, described separately for women after vaginal and cesarean deliveries. Among women who received a prescription, we additionally assessed associations between prescription quantity and subjective (patient-reported pain score) and objective (inpatient opioid requirement during the final 24 hours of hospitalization) assessments of pain. Descriptive and bivariable analyses were performed. RESULTS: Of the total 12,611 women, 12,326 were eligible for inclusion. Of 9038 women postvaginal delivery and 3288 women postcesarean delivery, 30.4% and 86.7% received an opioid prescription at discharge, respectively. Of women receiving discharge opioid prescriptions, median morphine milligram equivalents received was 200 (interquartile range: 120-300) following vaginal and 300 (interquartile range: 200-300) following cesarean delivery. Nearly half (45.7%) of women postvaginal delivery and 18.5% of women postcesarean delivery who received an opioid prescription used 0 morphine milligram equivalent during the final hospital day. Similarly, 26.5% and 18.5% of women after vaginal and cesarean delivery, respectively, reported a pain score of 0 of 10 prior to discharge. Regardless of delivery mode, the amount of opioids prescribed did not differ between those who reported a pain score of 0 of 10 and those who reported a pain score of >0 of 10 immediately prior to discharge. Similarly, for women who underwent cesarean delivery, the morphine milligram equivalents prescribed did not differ between those who used 0 morphine milligram equivalents and those who used >0 in the 24 hours prior to hospital discharge. CONCLUSION: Postpartum women are commonly prescribed opioids at the time of postpartum hospital discharge. There is a wide range of morphine milligram equivalents prescribed at hospital discharge following delivery, highlighting a lack of standardization. Furthermore, regardless of objective and subjective measures of pain prior to discharge, women received similar amounts of prescription morphine milligram equivalents following either vaginal or cesarean deliveries.

来源:Am J Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Badreldin N, Grobman WA, Chang KT, et al. Opioid prescribing patterns among postpartum women. Am J Obstet Gynecol. 2018. PMID: 29630887. doi:10.1016/j.ajog.2018.04.003

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。